1672-1535
2009 Issue 4
zhi chang ai fu zhu zhi liao xin jin zhan
li yu sheng
li yu sheng
..............page:407-412
Hematopoietic growth factors in chemotherapy
shao ya juan ; chen shu chang
shao ya juan ; chen shu chang
..............page:413-417
kang zhong liu ba xiang yao wu de xin xue guan bu liang fan ying
sun yan ; gao ying
sun yan ; gao ying
..............page:392-398
biao pi sheng chang yin zi shou ti yi zhi ji xiang guan pi fu bu liang fan ying de fa sheng ji zhi yu fang zhi
wang yu yan ; wang jie
wang yu yan ; wang jie
..............page:399-406
..............page:418-421
..............page:379-386,378,349
..............page:387-391
wan qi fei xiao xi bao fei ai hua liao xin jin zhan
li wei ; zhou cai cun
li wei ; zhou cai cun
..............page:359-364,358
..............page:365-369
..............page:347-348
fei xiao xi bao fei ai fen qi xian zhuang ji jin zhan
chen dong hong
chen dong hong
..............page:349-358
Standardization of concurrent radiochemotherapy in locally advanced NSCLC
zhu guang ying ; shen ge
zhu guang ying ; shen ge
..............page:370-378
Clinical observation in thalidomide combined with FoLFIRI in treatment of advanced colorectal cancer
wang qiong ; xu chen ; wang nan yao ; sheng hua ming ; fei yan hua ; wu dan
wang qiong ; xu chen ; wang nan yao ; sheng hua ming ; fei yan hua ; wu dan
..............page:460-461,471
Efficacy and safety of gefitinib in treating clinically selected patients with advanced non-small cell lung cancer
wang hui juan ; wang qi ming ; zhu hui ; he chun yu ; li peng ; ma zhi yong
wang hui juan ; wang qi ming ; zhu hui ; he chun yu ; li peng ; ma zhi yong
..............page:462-467
Relationship between the clinical efficacy and expression of lung cancer resistance protein genes in non-small cell lung cancer
liu xin yan ; yang yong hui ; xu shi ming ; liu ying ; sun jin zuo
liu xin yan ; yang yong hui ; xu shi ming ; liu ying ; sun jin zuo
..............page:468-471
Chemotherapy impact on the QOL of the patient with non-small cell lung cancer
tang dong jun ; zhang li hua
tang dong jun ; zhang li hua
..............page:472-475
Clinical study on variations of parotid volume in intensity modulated radiotherapy for nasopharyngeal carcinoma
zhang xi mei ; cao jian zhong ; luo jing wei ; xu guo zhen ; gao li ; yi jun lin ; huang xiao dong ; xiao jian ping ; li su yan
zhang xi mei ; cao jian zhong ; luo jing wei ; xu guo zhen ; gao li ; yi jun lin ; huang xiao dong ; xiao jian ping ; li su yan
..............page:431-435
Comparison of the dosages of IMRT and 3 DCRT for cervical carcinoma
huang man ni ; li ming hui ; wu ling ying ; an ju sheng ; dai jian rong
huang man ni ; li ming hui ; wu ling ying ; an ju sheng ; dai jian rong
..............page:436-441,435
A preliminary analysis of preoperative intensity-modulated radiotherapy and an incorporated boost with concurrent capecitabine for distal rectal cancer
yao bo ; zheng ming min ; zhang yan ; chen jian ping ; xu wei dong ; gao jun mao
yao bo ; zheng ming min ; zhang yan ; chen jian ping ; xu wei dong ; gao jun mao
..............page:442-447
Clinical study of gefitinib on the first or second line to treat old age advanced NSCLC
zhang gang ; sun xiu hua ; zhao hui bo ; zhang xian ; liu fang ; yang xiao yan ; dai chao xia
zhang gang ; sun xiu hua ; zhao hui bo ; zhang xian ; liu fang ; yang xiao yan ; dai chao xia
..............page:448-455
Comparative study of FOLFOX and gcmcitabine plus cisplatin regimen in treatment of the advanced pancreatic cancer
jing nian cai ; yang ji li
jing nian cai ; yang ji li
..............page:456-459,455
ru xian ai de fen zi ya xing ji zhi liao ce lue yan jiu jin zhan
ni xin chu ; sun su ping
ni xin chu ; sun su ping
..............page:422-426
di yang you dao yin zi -1 zai yi xian ai zhong de yan jiu jin zhan
qiu zhi dong ; zuo hui lai
qiu zhi dong ; zuo hui lai
..............page:427-430,421